Global Cell Signaling Market By Type (Paracrine Signaling, Endocrine Signaling, Autocrine Signaling, and Others), By Product (Consumables and Instruments), By Technology (Western Blotting, Microscopy, Flow Cytometry, ELISA, and Others), By Pathway (ErbB/HER, AMPK, AKT, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Feb 2025
- Report ID: 139457
- Number of Pages: 363
- Format:
-
keyboard_arrow_up
-
-
- QIAGEN NV Company Profile
- Merck KGaA Company Profile
- Danaher Corporation Company Profile
- Cell Signaling Technology Inc.
- Bio-Techne Corporation
- Bio-Rad Laboratories Inc.
- Becton, Dickinson and Company Profile
- settingsSettings
Our Clients
- 139457
- Feb 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
